A new study from Brigham and Women’s Hospital researchers have data and new analysis tools will be used to address this question in four common diseases: rheumatoid arthritis, celiac disease, coronary heart disease and myocardial infarction and type 2 – diabetes.

– to show after senior author Robert Plenge, BWH Director of genetics and genomics in the Department of Rheumatology, Immunology and Allergy, We have GWAS data and a Bayesian statistical framework, that a substantial amount of risk for these four common diseases is on loci loci that are common causal variants harbor with little effect, and a small number of loci rare rare causal variants. .. The method uses data from previously published genome-wide association studies or GWAS, uses an approach that seen by DNA samples for the genetic markers in the population scan – called SNPs .Atrial fibrillation affects over 2.2 million people in the U.S. And may cause fatigue, shortness of breath, exercise intolerance and palpitations. Compared to people without atrial fibrillation, are those who suffered with the disorder five times more likely till up to a two fold greater risk of death. In some patients, medications able control heart rhythm disorders and the risk clots affiliated with atrial fibrillation, however in contrast to the Cox-Maze A method, the drugs do not cure the disease.

##Lall SC, Melby SJ, Voller RK, Decoraters A, Bailey Microsoft, Guthrie TJ, Age of MR, Moazami north, Lawton JS, Damian RJ. The effects of ablate technology on operation results after to Cox Maze procedure: An inclination of analysis. Journal of of Thoracic and Cardiovascular Surgery 2007 Feb, 133 :389-96. Ralph Damian get consulting and received lecture fees from Atricure and Medtronic and aid from Atricure.

Funding from which NIH supporting this research.